FundedIQ
Health Care

CeQur

CeQur Simplicity helps people with diabetes by developing drug-delivery devices. They develop bolus insulin delivery devices that allow a person to administer insulin by clicking the buttons. They work with physicians and centers to bring technology to patients.

myceqursimplicity.com Horw, Switzerland 101-250 employees
Total raised
$100M
Rounds
1
Latest
Series E
Jun 2026

CeQur Simplicity helps people with diabetes by developing drug-delivery devices. They develop bolus insulin delivery devices that allow a person to administer insulin by clicking the buttons. They work with physicians and centers to bring technology to patients.

CeQur has raised $100M across 1 round. Its most recent round was a Series E of $100M in Jun 2026. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Jun 9, 2026
Series E
$100M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

CeQur is featured in

Similar companies

MoleSense

MoleSense is to provide a wearable skin sensor to help monitor high-risk pregnancies.

Series Unknown $110k
Calmea

Calmea develops advanced contactless sensing systems that invisibly track sleep and automatically modify environment for perfect nightly rest

Series Unknown $190k
Nuclidium

NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.

Series B $33.6M
UNBOOUND

UNBOOUND is a medtech company and university spin-off (The Rockefeller University and University of Geneva) that specialises in human olfactory (smell) assessment.

Series Unknown $130k
Terapet

Christina Vallgren and Marcus Palm, two physicists from CERN, co-founded Terapet along with Professor Raymond Miralbell from Geneva University Hospitals (HUG). Having demonstrated the potential of their idea, they are currently working on creating an initial version of their product for commercial release.

Series Unknown $2.6M
Clee Medical
Seed
Axmed

Axmed is a company that specializes in serving low and middle-income countries (LMICs), with the goal of enhancing their ability to purchase affordable, high-quality medicines. We collaborate only with reputable pharmaceutical companies and certified healthcare providers to expedite the availability of medications.

Series Unknown $6.0M
Babylat

Babylat is an enricher device is the first automated, small-scale tabletop device for the protein enrichment of human milk.

Series Unknown $1.0M
Altiscreen

Altiscreen is creating and producing cutting-edge, portable drug-of-abuse detection systems. With the use of our technology, law enforcement, medical professionals, and other organizations may quickly and accurately screen for drug addiction in the field.

Series Unknown $150k
Vivent

Vivent provides growers, breeders and agrochem companies with actionable information direct from plants themselves. We help clients see how and when plants respond to changing conditions and we provide early warning (days before visual symptoms) of abiotic and biotic stressors. With better information on plant responses, growers optimise conditions and have increased yields and fruit quality. Early warning enables more effective and environmentally preferable crop protection. Plant scientists accelerate agrochem product development and improve use recommendations. Breeders can identify beneficial traits in real-time.

Series Unknown $8.7M
Multiwave Technologies

Multiwave develops breakthrough Magnetic Resonance Imaging and Positron Emission Tomography devices. Founded in Switzerland in March 2015, Multiwave Technologies AG has its headquarters in Geneva, Switzerland and a R&D facility in France.

Venture - Series Unknown $4.5M
Qumea

Qumea provides a unique solution for discreet patient monitoring. By fusing AI and 3D radar technology, QUMEA protects the patient and disburdens the care.

Series Unknown
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.